Exozymes Income Statement (2023-2024) | EXOZ

Income Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024
Revenue & cost
Revenue -700.00-0.04M
Operating items
Research & Development 0.03M0.46M0.28M0.24M0.72M0.63M
Wages, Salaries and Other 0.12M0.29M0.39M0.73M0.55M0.86M
Selling, General & Administrative 0.36M0.52M0.73M1.09M0.89M1.35M
Restructuring Costs 0.15M0.08M0.08M0.06M0.06M0.13M
Other Operating Expenses -0.15M-0.08M-0.08M-0.06M-0.06M-0.13M
Operating Expenses 0.39M0.98M1.01M1.33M1.61M1.98M
Operating Income -0.39M-0.99M-1.01M-1.33M-1.61M-1.98M
EBIT -0.39M-0.99M-1.01M-1.33M-1.61M-1.98M
Non-operating items
Interest & Investment Income -0.03M-0.04M0.15M
Other Non Operating Income -0.13M-0.07M
Net income details
EBT -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Tax Provisions 0.00M-1.00
Profit After Tax -0.52M-1.10M-1.01M-1.36M-1.66M-1.84M
Income from Continuing Operations -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Consolidated Net Income -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Income towards Parent Company -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Net Income towards Common Stockholders -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Additional items
EPS (Basic) -0.08-0.17-0.16-0.22-0.27-0.25
EPS (Weighted Average and Diluted) -0.08-0.17-0.16-0.22-0.27-0.25
Shares Outstanding (Weighted Average) 6.25M6.25M6.25M6.25M6.25M
Shares Outstanding (Diluted Average) 6.25M6.25M6.25M6.25M6.25M
EBITDA -0.39M-0.99M-1.01M-1.33M-1.61M-1.98M
Interest Expenses 0.04M
Shares Outstanding 6.25M6.25M6.25M6.25M6.25M
Tax Rate -0.160.00